Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

NCT04098744 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

CIN 2/3
HPV Infection
Pre-Cancerous Dysplasia
Cervical Dysplasia
HPV Related Disease

Interventions

DRUG: Artesunate vaginal insert
DRUG: Placebo vaginal insert

Sponsor

Frantz Viral Therapeutics, LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]